A simple, sensitive, fast, and accurate isocratic high-performance liquid chromatography (HPLC) method with UV detection (205 nm) has been developed and validated for the quantification of latanoprost (in nanogram level) in pure and commercial dosage form. An Agilent Eclipse XDB-C18 column (150 × 4.6 mm i.d., 3.5 μm particle size) was used. Chromatography was performed with a mobile phase containing a mixture of acetonitrile and water (70:30, v/v) containing 0.1% v/v trifluoroacetic acid, adjusted at pH 3.0 at a flow rate of 1 mL min−1. Each analysis required 3.0 min including triamcinolone acetonide as an internal standard. The method was validated for linearity, accuracy, precision, specificity, system suitability, and robustness. The calibration curve was linear in the concentration range 0.0125–1 μg mL−1; the correlation coefficient was 0.999. The method proved to be accurate, precise, specific, rapid, and reproducible according to ICH standards. The method showed good recoveries (average 100.15 %), and the relative standard deviations of intra- and inter-day were <2.0%. This method is novel since there has been no report about analysis of latanoprost at ng mL−1 levels using a simple HPLC method. Besides regular quality control assay of latanoprost in raw material and in commercial formulations, this method has key importance for scientists working on sustained drug delivery system of latanoprost in which quantification in nanogram levels is one of the most important parameters.
[1]. J. Stjernschantz B. Resul 1992 Drugs Future 17 691.
[2]. B. Resul J. Stjernschantz K. No C. Liljebria G. Selen M. Astin M. Karlsson L.Z. Bito 1993 J Med. Chem. 36 243.
[3]. S. Basu B. Sjöquist J. Stjernschantz B. Resul 1994 Prostaglandins, Leukotrienes Essent. Fatty Acids 50 161.
[4]. B. Sjöquist S. Basu K. Bergh P. Byding 1994 Exp. Eye Res. 59 Suppl1 146.
[5]. B.T. Gabelt P.L. Kaufman 1989 Exp. Eye Res. 49 389.
[6]. P.L. Kaufman K. Crawford 1989 Prog. Clin. Biol. Res. 312 387.
[7]. S.F. Nilsson M. Samuelsson A. Bill J. Stjernschantz 1989 Exp. Eye Res. 48 707.
[8]. K. Higaki K. Kamata M. Takeuchi K. Inazawa T. Chikai T. Hamaguchi T. Yukawa K. Kadono S. Kawahara M. Nakano 1995 Drug Metab. Dispos. 23 35.
[9]. S. Basu B. Sjöquist 1996 Prostaglandins, Leukotrienes Essent. Fatty Acids 55 427.
[10]. B. Sjöquist S. Basu P. Byding K. Bergh J. Stjernschantz 1998 Drug Metab. Dispos. 26 745.
[11]. B. Sjöquist J. Stjernschantz 2002 Surv. Ophthalmol. 47 Suppl1 6.
[12]. B. Sjöquist A. Uhlin P. Byding J. Stjernschantz 1999 Arzneimittelforschung 49 234.
[13]. B. Calissendorff B. Sjöquist G. Hogberg A. Grunge-Lowerud 2002 J. Ocul. Pharmacol. Ther. 18 127.
[14]. V. Redulescu C. Doneanu C. Mandruta F. Cocu 1997 Rev. Roum. Chim. 42 1129.
[15]. P.V. Morgan S. Proniuk J. Blanchard R.J. Noecker 2001 J. Glaucoma 10 401.
[16]. Y. Sakai S. Yasueda A. Ohtori 2005 Int. J. Pharm. 305 176.
[17]. R. Varma J. Winarko T. Kiat-Winarko B. Winarko 2006 Invest. Ophthalmol. Visual Sci. 47 222.
[18]. M. Ashfaq I.U. Khan M.N. Asghar 2006 Anal. Lett. 39 2235.
[19]. P. Widomski P. Baran P. Golebiewski I. Surowiec A. Bielejewska 2008 Acta Chromatogr. 20 157.
[20]. M.D. Paolera N. Kasahara C.C. Umbelino J.G. Walt 2008 BMC Ophthalmol. 8 11.
[21]. ICH Topic Q2 (R1): Validation of Analytical Procedures: Text and Methodology, 1996.
[22]. G.A. Shabir 2003 J. Chromatogr. A 987 57.
[23]. G.A. Shabir 2010 Separation Sci. Tech. 45 670.
[24]. U.S. Pharmacopeia 32, Chromatography, Section (621), United States Pharmacopeial Convention, Rockville Maryland, 2009, p. 1776.
[25]. C. Akay I.T. Degim A. Sayal A. Aydin Y. Ozkan H. Gul 2008 Turk J. Med. Sci. 38 161.